Submission of postal ballot notice
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Remedium Lifecare Limited has issued a postal ballot notice seeking shareholder approval through e-voting on three special resolutions. The voting window runs from November 8, 2025 to December 7, 2025. First, the company proposes changing its name to 'Supha Pharmachem Limited' to better reflect its evolving pharmaceutical business (the name has already been approved by MCA's Central Registration Centre). Second, shareholders are asked to approve the appointment of Mr. Vignesh Laxman Gawde (DIN: 11360925) as Whole Time Director for 5 years (till October 30, 2030) at a remuneration of Rs. 50,000 per month. Third, shareholders are asked to approve Mr. Rambhajan Vishwakarma (DIN: 11360922) as Non-Executive, Non-Independent Chairman. Notably, the Nomination and Remuneration Committee was dissolved at the time of these appointments due to resignations, which is a governance red flag. The company trades in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates.
The name change signals a strategic rebranding toward pharmaceutical chemicals, though core business objects remain unchanged. Two new directors bring pharma research and banking experience to the board. Shareholders should note the NRC was non-functional at the time of these key appointments, which weakens governance checks.